Efficacy and safety of osilodrostat in patients with Cushing's disease (LINC 3): a multicentre phase III study with a double-blind, randomised withdrawal phase

著者: Rosario Pivonello, Maria Fleseriu, John Newell‐Price, Xavier Bertagna, James W. Findling, Akira Shimatsu, Feng Gu, Richard J. Auchus, Rattana Leelawattana, Eun Jig Lee, Jung Hee Kim, André Lacroix, Audrey Laplanche, P.R. O'Connell, Libuse Tauchmanovà, Alberto M Pedroncelli, Beverly M. K. Biller - The Lancet 2020 被引用: 211